Key Takeaways
- •<p>Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a naturally occurring protective protein found in human gastric juice.
- •<h2>Amino Acid Sequence & Molecular Profile</h2>
- •<p>BPC-157 has the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1419.53 Da.
<p>Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a naturally occurring protective protein found in human gastric juice. It has become one of the most widely studied peptides in preclinical research, with over 100 published studies exploring its effects on tissue repair, angiogenesis, and cytoprotective pathways in laboratory and animal models.</p>
<h2>Amino Acid Sequence & Molecular Profile</h2>
<p>BPC-157 has the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1419.53 Da. Unlike many peptides, BPC-157 is notable for its stability in gastric acid — a property that has led researchers to investigate both injectable and oral administration routes in animal models. The peptide does not have a known receptor target in the classical sense; instead, it appears to modulate multiple signaling pathways simultaneously.</p>
<h2>Mechanism of Action in Preclinical Models</h2>
<p>Research suggests BPC-157 exerts its effects through several interconnected mechanisms:</p>
<ul>
<li><strong>Angiogenesis promotion:</strong> BPC-157 has been shown to upregulate VEGF (vascular endothelial growth factor) expression in vitro, promoting the formation of new blood vessels in wound-healing models.</li>
<li><strong>Nitric oxide (NO) system modulation:</strong> Studies indicate interactions with the NO system, which plays a central role in vascular tone, inflammation, and tissue repair processes.</li>
<li><strong>Growth factor upregulation:</strong> Preclinical data shows increased expression of EGF, FGF, and other growth factors in tissue models exposed to BPC-157.</li>
<li><strong>Anti-inflammatory activity:</strong> In rodent models, BPC-157 has demonstrated the ability to reduce inflammatory cytokine expression, including TNF-α and IL-6.</li>
<li><strong>FAK-paxillin pathway activation:</strong> This signaling cascade is involved in cell migration and adhesion, which are critical components of wound closure.</li>
</ul>
<h2>Key Research Findings</h2>
<p>The body of preclinical literature on BPC-157 spans multiple organ systems and injury models. Notable areas of investigation include:</p>
<ul>
<li><strong>Gastrointestinal models:</strong> Studies in rats have shown accelerated healing of gastric ulcers, intestinal anastomosis, and inflammatory bowel conditions when treated with BPC-157.</li>
<li><strong>Musculoskeletal models:</strong> Tendon-to-bone healing, muscle crush injuries, and ligament transection models have all shown improved outcomes in BPC-157-treated groups.</li>
<li><strong>Neuroprotection:</strong> Several studies have explored BPC-157's effects on peripheral nerve damage and spinal cord injury models, with promising results in terms of functional recovery.</li>
</ul>
<p>It is important to note that the vast majority of these studies have been conducted in rodent models. No large-scale human clinical trials have been completed as of 2026, and BPC-157 is not approved by the FDA or any equivalent regulatory body for therapeutic use.</p>
<h2>Evaluating Purity: What Researchers Should Look For</h2>
<p>When sourcing BPC-157 for research, purity documentation is essential. A reliable <a href="/quality">Certificate of Analysis (COA)</a> should include:</p>
<ul>
<li><strong>HPLC purity ≥98%:</strong> High-performance liquid chromatography is the gold standard for peptide purity assessment. Research-grade BPC-157 should consistently exceed 98% purity.</li>
<li><strong>Mass spectrometry confirmation:</strong> MS data verifies that the molecular weight matches the expected value for BPC-157 (1419.53 Da), confirming identity.</li>
<li><strong>Endotoxin testing:</strong> For in vitro cell culture work, endotoxin levels should be documented and below acceptable thresholds.</li>
<li><strong>Batch-specific documentation:</strong> Each lot should have its own COA, not a generic document reused across batches.</li>
</ul>
<p>At Volta Peptides, every batch of <a href="/catalog">BPC-157</a> ships with a batch-specific COA including HPLC chromatograms and mass spectrometry data. You can learn more about our testing protocols on our <a href="/quality">Quality & COAs page</a>.</p>
<h2>Key Takeaways</h2>
<ul>
<li>BPC-157 is a 15-amino-acid synthetic peptide derived from human gastric juice proteins.</li>
<li>Preclinical research suggests multi-pathway mechanisms involving angiogenesis, NO modulation, and growth factor upregulation.</li>
<li>Over 100 studies have explored BPC-157 in tissue repair models, but no human clinical trials have been completed.</li>
<li>Researchers should evaluate suppliers based on batch-specific COAs with HPLC ≥98% and mass spectrometry confirmation.</li>
</ul>
<div style="margin-top:2rem;padding:1rem;background:#faf7f0;border-radius:8px;border:1px solid #f0ebe4;"><p style="font-size:0.85rem;color:#6F696A;margin:0;"><strong>Disclaimer:</strong> All compounds referenced in this article are intended for in vitro research use only and are not approved for human or veterinary use. This article does not constitute medical advice. Researchers should consult applicable regulations and institutional guidelines before beginning any study.</p></div>